|
Covidien completes USD 2.6 billion purchase of ev3 |
|
Tuesday, 13 July 2010 |
Covidien has completed its USD 2.6 billion acquisition of endovascular surgery device maker, ev3 Inc. Covidien announced plans to buy the company for USD 22.50 per share on June 1. Ev3 makes devices used in endovascular surgeries, or operations in which surgeons make small incisions and maneuver devices in the body through major blood vessels. Other products are used in neurovascular procedures, or procedures involving both blood vessels and nerves. The company is based in Plymouth, Minn., and will become part of Covidien's vascular products business.
|
